SMN Antibodies

Santa Cruz Biotechnology provides a broad selection of SMN monoclonal antibodies for investigating the Survival Motor Neuron (SMN) protein. SMN monoclonal antibodies are compatible with multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). The SMN protein is essential for the assembly of spliceosomal small nuclear ribonucleoproteins and plays a vital role in the maintenance of motor neurons. Deficiencies in SMN protein levels are linked to spinal muscular atrophy (SMA), a severe genetic disorder that leads to muscle weakness and atrophy. Understanding the function and regulation of SMN is crucial for developing therapeutic strategies for SMA and related conditions. Researchers worldwide rely on SMN monoclonal antibodies to study protein expression patterns in various cell types and tissues. Advanced research techniques using SMN monoclonal antibodies help reveal cellular mechanisms and potential therapeutic targets. Ongoing studies with SMN monoclonal antibodies continue to expand knowledge about neurodegenerative processes. Santa Cruz Biotechnology monoclonal antibodies support researchers in advancing scientific understanding of neurodegenerative diseases and potential treatments.